Promising new treatment for rare Muscle-Weakening disease enters human trials

NCT ID NCT07103746

Recruiting now Disease control Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 11, 2026 · Updated 2 times

Summary

This study tests a drug called ublituximab for people with a rare autoimmune disease that causes severe muscle weakness. The goal is to see if adding this drug to standard treatment improves muscle strength and function more than standard treatment alone. About 30 adults with early-stage disease will take part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTOIMMUNE DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autoimmune disease immune-mediated necrotizing myopathy myositis disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AUTOIMMUNE DISORDERS

Contacts and locations

Locations

Emory University School of Medicine: Division of Rheumatology
NOT_YET_RECRUITING

Atlanta, Georgia, 30322, United States
Johns Hopkins Hospital: Division of Rheumatology
RECRUITING

Baltimore, Maryland, 21244, United States
Mayo Clinic: Division of Rheumatology
NOT_YET_RECRUITING

Rochester, Minnesota, 55905, United States
Northwell Health: Division of Rheumatology and Allergy-Clinical Immunology
NOT_YET_RECRUITING

Great Neck, New York, 11021, United States
University of Alabama at Birmingham School of Medicine: Division of Clinical Immunology & Rheumatology
NOT_YET_RECRUITING

Birmingham, Alabama, 35233, United States
University of Chicago, Department of Medicine: Rheumatology
NOT_YET_RECRUITING

Chicago, Illinois, 60637, United States
University of Pittsburgh Medical Center: Division of Rheumatology and Clinical Immunology
NOT_YET_RECRUITING

Pittsburgh, Pennsylvania, 15261, United States
University of Texas - Houston
RECRUITING

Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.